ScholarLens Back to search
2001•International Journal of Radiation Oncology*Biology*PhysicsRequires access

Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non–small-cell lung cancer: A randomized trial

Branislav Jeremic, Yuta Shibamoto, Ljubiša Aćimović, Biljana Miličić, Slobodan S. Milisavljevic, Nebojsa Nikolic, Aleksandar Dagović, Jasna Aleksandrovic, Gordana D. Radosavljevic-Asic

Open publisher page 52 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 52 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Carboplatin, Etoposide, Medicine, Chemotherapy, Urology, Toxicity, Internal medicine, Oncology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Hyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non–small-cell lung cancer: A randomized trial — Research Paper | ScholarLens